We have previously studied a collection of group G streptococcal strains isolated from bacteremic human infections and demonstrated that such strains resist phagocytosis by human polymorphonuclear leukocytes but are type specifically opsonized by homologous antiserum. We have now performed Southern hybridization analysis on genomic DNA from eight blood isolates. All eight isolates showed DNA homology to a group A emm24 gene probe. The M-protein gene of one of the isolates, strain 1750, has now been isolated. This gene (emmGl) encodes a polypeptide of 67 kDa (MG1) which is reactive with antibodies to the partially purified M protein of the parent strain. The predicted amino acid structure of MG1 demonstrates significant identity with the carboxy terminus (C, D, and anchor domains) of M6 and M24 but only limited identity with the amino terminus (variable portion) of these group A M proteins. Southern hybridization of genomic DNA of the eight group G blood isolates with an emmGl gene probe indicated there were at least four emm alleles associated with these strains. These studies indicate that M proteins of group G streptococci, like those of group A, are genetically heterogeneous. Moreover, MG1 appears to conform to the recently proposed class I structure of M-protein molecules and thus shares certain distinct structural features with the M proteins of well-established rheumatogenic group A streptococcal serotypes. Further comparison of the structures of group G and group A M proteins of throat and skin isolates may cast light on those configurations of the M protein molecules which are and are not critical for the expression of rheumatogenicity.
Group G streptococci were first identified by Lancefield and Hare (26) over a half century ago. Although these organisms are part of the normal microbial flora of the skin, pharynx, vagina, and gastrointestinal tract of humans, there has been increasing recognition in recent years that group G streptococci may cause life-threatening human infections. These have included bacteremia, infective endocarditis, suppurative thrombophlebitis, arthritis, osteomyelitis, empyema, peritonitis, endometritis, and neonatal sepsis (1, 12, 13, 16, 18, 25, 29, (37) (38) (39) .
Little is known of the mechanisms by which group G streptococci exert their virulence. The group A streptococcus (Streptococcus pyogenes) is by far the most extensively studied of the pathogenic beta-hemolytic streptococci because of its association with acute rheumatic fever. The principal virulence factor of S. pyogenes is a cell wall constituent known as M protein. M protein is antiphagocytic, and antibodies to specific M serotypes are generally accepted as being the basis of acquired human immunity to group A streptococcal infections.
We have previously identified surface protein constituents analogous to the M proteins of group A streptococci in group G streptococcal strains isolated from life-threatening bacteremic human infections (10) . These organisms multiplied luxuriantly when rotated in fresh human blood but were readily phagocytosed and killed in the presence of antisera raised against partially purified M-protein preparations fromn the homologous group G strain. Other investigators have demonstrated biological and immunochemical identity be-carbenicillin (100 ,ug/ml) when necessary. Streptococcal strains were grown either in Todd-Hewitt broth or on 5% sheep blood agar plates.
Serum opacity factor assay. The assay was performed by the method of Top and Wannamaker (36) .
N-terminal amino acid analysis of strain 1750 M protein. Peptic extraction of M protein was performed by the method of Beachey et al. (3) as previously described (10) . The fraction of the extract which precipitated with 30 to 60% ammonium sulfate was dialyzed in phosphate-buffered saline (pH 7.4), lyophilized, reconstituted, and applied to 10% polyacrylamide gels containing 0.1% sodium dodecyl sulfate (SDS). The peptides present on the SDS-polyacrylamide gels were transferred electrophoretically to nitrocellulose paper and stained with Coomassie brilliant blue. Three major bands were observed, as previously reported (10) and illustrated in Fig. 4 . The amino acid sequence of the most slowly migrating band was determined in the laboratory of Keith Brew (Department of Microbiology, University of Miami School of Medicine) by Edman degradation, using an automated protein sequencer (Applied Biosystems).
Western immunoblot analysis. Western blot analysis using whole-cell lysates of E. coli was performed as described previously (24) . The blot was reacted with a 1:200 dilution of rabbit antiserum raised against the 30 to 60% ammonium sulfate fraction of pepsin-extracted M protein of strain 1750. This antiserum is type specifically opsonic for strain 1750. Specifically bound antibodies were then detected by incubation with a 1:1,000 dilution of goat anti-rabbit immunoglobulin G-peroxidase conjugate (Sigma) followed by development in a solution of 4-chloro-1-naphthol (0.5 mg/ml; Sigma) plus hydrogen peroxide (0.01%).
Nucleic acid isolation and restriction. Plasmid DNA was isolated from E. coli by alkaline lysis (27) . Streptococcal genomic DNA was isolated by the method of Cleary et al. (14) . Restriction enzymes were purchased from either New England Biolabs, Inc., Beverly, Mass., or Bethesda Research Laboratories, Inc., Gaithersburg, Md. Enzymatic reaction conditions were those recommended by the manufacturer.
Construction of recombinant plasmids. For the construction of p1750-1, strain 1750 genomic DNA was digested to completion with PvuII, and the approximately 2.0-kb fragments were isolated after electrophoresis through a 1% low-melting-point agarose gel. The purified fragments were ligated, using T4 DNA ligase (Bethesda Research Laboratories), to PvuII-digested, alkaline phosphatase-treated pBR322. The resulting E. coli DH5at transformants were screened by colony hybridization for homology to the emm24 gene probe (for description, see below).
To construct p1750-7, 2.6-kb XbaI fragments of strain 1750 genomic DNA were isolated from low-melting-point agarose and ligated to XbaI-digested, alkaline phosphatase-treated pUC19. The recombinant plasmid containing the emm24-homologous XbaI fragment was termed p1750-6. This 2.6-kb XbaI fragment was isolated from p1750-6 and inserted downstream of the 0.3-kb PvuII-to-XbaI fragment from p1750-1 in pGEM7Zf(-). The resulting plasmid containing the XbaI fragment in the proper orientation was named p1750-7.
DNA sequence analysis. DNA was sequenced by using the dideoxy method of Sanger et al. (30) as modified for use with Sequenase (U.S. Biochemical). Various p1750-7 subclones were constructed in pGEM7Zf(-), pGEM3Zf(-), or pGEM3Zf(+) (Promega). Single-stranded DNA templates derived from these subclones were sequenced by using oligonucleotide primers homologous to either the T7 or SP6 promoter encoded on the plasmids or primers designed to be internal to the cloned DNA fragment. Single-stranded DNA was prepared from inserts in pGEM vectors by using phage R408 as described by the manufacturer (Promega). [35S] dATP-labeled DNA fragments were separated by electrophoresis on 6% acrylamide gels and visualized by autoradiography.
Southern Nucleotide sequence accession number. The GenBank accession number for the emmGl sequence presented here is M95774.
RESULTS
Group G strains contain DNA homologous to group A M-protein genes. Previous studies on seven group G strains isolated from clinically severe bacteremic infections indicated that these strains expressed antiphagocytic surface proteins analogous to the M proteins from group A streptococci (10). We performed Southern hybridization analysis on genomic DNA from the seven strains plus one additional strain isolated from a human bacteremic infection. The DNA probe corresponded to the carboxy-terminal one-third of the group A M-protein gene emm24 (this probe will be referred to as the emm24 gene probe). This region is highly conserved in all M proteins studied thus far. Genomic DNA from all eight strains showed homology to the probe under stringent hybridization conditions (Fig. 1) .
Serum opacity factor. All eight strains under study were opacity factor negative.
Isolation of an M-protein gene from group G strain 1750. An M-protein-encoding gene from strain 1750 was isolated by using the DNA homology seen between the emm24 gene probe and genomic DNA from group G strains. Group G strain 1750 genomic DNA was digested with various restriction endonucleases that have 6-bp recognition sites and hybridized to the emm24 gene probe. The probe recognized a 2-kb PvuII fragment and a 2.6-kb XbaI fragment of strain (Fig. 4 , lane 5).
(Presumably these various forms represent proteolytic degradation products of the same polypeptide.) There was no reactive material detected in any of the other E. coli extracts examined (Fig. 4, lanes 2 to 4) . The amino-terminal amino acid sequence of MG1. The amino-terminal sequence of the major polypeptide isolated from the pepsin-extracted surface material of strain 1750 was determined to confirm that emmGl corresponded to our biologically active material. The sequence of the first 12 amino-terminal amino acids was Glu-Asn-Thr-Asp-Gln-TyrAsp-Gln-Tyr-Val-Lys-Lys. This sequence corresponds exactly with the predicted amino acid sequence of residues 42 to 53 of the emmGl-encoded polypeptide. The amino-terminal sequence at residue 42 suggested that the first 41 amino acids were removed from the mature protein, implicating the presence of a signal peptide.
Comparison of emmGI with other M-protein genes. The GenBank data base was scanned for sequences homologous to that of emmGl DNA. The emmGl DNA sequence showed a high degree of identity to sequences of eight different streptococcal M-protein genes, including 67% nucleotide residue identity with emml2, encoding M protein type 12 from S. pyogenes; 61% nucleotide residue identity with emm24, encoding S. pyogenes M protein type 24; and 65% nucleotide residue identity with emm6, encoding S. pyogenes M protein type 6.
Comparison of the predicted amino acid sequence of MG1 with the amino acid sequences of various M proteins provided additional evidence that emmGl encodes an M protein. There were two regions of homology between MG1 and the other M proteins. The first 41 amino acids of the predicted MG1 sequence have 74 and 76% amino acid residue identity with the amino acid signal peptides of M6 (Fig. 5A) and M24, respectively. Therefore, the first 41 amino acids of MG1 represent the signal peptide of the protein. This observation is consistent with the N-terminal amino acid sequence of mature MG1 originating at amino acid 42 (see above).
The second region of homology was the 208 amino acids at the carboxy terminus. This region of the predicted amino acid sequence of MG1 shows 94 and 86% identity with the carboxy-terminal amino acid regions of M6 (Fig. SB to D) and M24, respectively. This terminal amino acid region encodes repeat C, repeat D, and the anchor domain of the M protein as defined by Hollingshead et al. (21) .
In terminal 40 amino acids of this region. Therefore, it appears that the terminal 40 amino acids of the B repeat of these proteins are somewhat conserved among the different M types. There was only sporadic amino acid identity throughout the other portion of the region. Serotypic data indicate that MG1 is antigenically distinct from group A M-protein types (10) . This difference in antigenicity can easily be attributed to differences in the A-and B-repeat regions.
MG1 contained a number of amino acid repeats in this variable region (e.g., ELDKKEQEL at positions 208 to 216, ELDQKEKEL at positions 229 to 237, QKEKEL at positions 225 to 230, and QKEKEL at positions 232 to 237); however, MG1 did not contain the prominent tandem repeats found in the A-and B-repeat regions of M6 and M24.
As for other M proteins, the predicted structure of MG1 was predominantly alpha helical. By using the DELPHI protein secondary structure analysis and the amino acid sequence of mature MG1, the structure of native MG1 was estimated to be 83% alpha helix. The only portion of the molecule devoid of alpha-helical structure was the prolineglycine-rich wall domain. Fourier analysis of the predicted amino acid sequence of the mature protein indicated that the alpha-helical region had a strand periodicity of 1/6, strongly indicating a coiled-coil structure. M6 and other M-protein types have been shown to exist as coiled-coil structures.
Not all M-positive group G strains contain emmGl. Genomic DNA from the original group G strains, with the addition of the eighth isolate (strain 3125), was probed with the 0.8-kb HindIII-to-HindIII fragment from p1750-7 (Fig.  6 ). This fragment codes for most of the variable region of MG1 and 68 amino acids of the C repeat. All eight strains contain DNA homologous to this emmGl gene probe.
The hybridization profiles (Fig. 6) indicate that the emm genes of group G strains 1750 and 1737 share restriction sites and most probably represent the same M-protein type. Group G strains 1434, 1395, and 1454 appear to contain emm genes similar to each other but distinct from the emm genes of other strains. Group G strains 3125 and 1618 appear to contain homologous emm genes, and strain 1714 appears to have a unique profile. The hybridization profiles suggest that there are at least four distinct emm alleles associated with group G streptococci. These results are in accord with opsonophagocytic studies (9) indicating shared opsonic determinants between strains 1750 and 1737 and between strains 1395 and 1434. GCT TTA GAA GAA GCA AAC AC AAA TTA GCT GCT CTT GAA AAA CTT MC AAA GAG Ala Leu Glu Glu Ala Asn Ser Lys Leu Ala Ala Leu Glu Lys Leu Asn Lys Glu
DISCUSSION
While previous studies from our laboratories and others (10, 22, 28, (31) (32) (33) indicate that group G streptococci encode and express M proteins, emmGl is the first reported group G streptococcal M-protein gene to be cloned and sequenced. emmGl was isolated on the basis of its homology to the terminal region of emm24, which encodes a portion of the C repeat, the D repeat, and the anchor domain of M24. There are a number of streptococcal proteins that contain a similar carboxy-terminal region, including M proteins, the immunoglobulin A-binding protein (20) , and the immunoglobulin G-binding protein of group G streptococcus (protein G) (17) .
The nucleotide sequence of emmGl, along with initial hybridization data obtained by using a protein G gene probe (a generous gift of Genex Corp., Gaithersburg, Md.), indicated that we have not isolated the gene encoding protein G. We believe that emmGl encodes an M protein, on the basis of (i) the immunoreactivity of the emmGl protein product with type-specific opsonizing antibodies raised to MG1 and (ii) the predicted structure of the emmGl-encoded protein. The predicted amino acid sequence of MG1 indicates it to be a mostly alpha-helical protein (83%) with a periodicity suggestive of a coiled-coil structure. These two findings are characteristic of M proteins. (6) (7) (8) 35) . Moreover, distinct structural differences between the M proteins epidemiologically associated with rheumatic fever and poststreptococcal glomerulonephritis have been described (23) .
Widdowson et al. (41) recognized antigenic differences in certain non-type-specific moieties (2) of M protein which they termed M-associated proteins (MAP) (40) . On the basis of these distinctions, they classified the most common M serotypes into two groups, MAP I and MAP II. MAP I included those serotypes classically associated with acute pharyngitis, including most of the highly immunogenic, opacity factor-negative types epidemiologically associated with rheumatic fever. Certain serotypes gave variable results and could not be definitely assigned an MAP type.
The significance of these earlier studies has now been placed in clearer perspective by utilization of modern molecular biologic techniques to elucidate M-protein structure. M-protein molecules share tandemly arranged blocks of repeating sequences. The C-terminal portion of the M-protein molecule is highly conserved among different serotypes, while the N terminus is much more variable from type to type (19 (4, 5) . The first two blocks of the C-repeat region (residues 386 to 469) contain all 40 of the invariant amino acid residues (underlined in Fig.  SB) and 7 of the 8 class I-specific amino acid residues (indicated by colons in Fig. SB) . Only the glutamic acid residue at position 442 is suggestive of a class II molecule. The fact that strain 1750 is opacity factor negative is further evidence of its class I structure (4) . Moreover, we have now succeeded in cloning emm genes from two additional strains in our collection (1395 and 1454), and the predicted amino acid sequences of the M proteins from both strains include all eight of the class I-specific residues (29a).
Strain 1750 was isolated from an intravenous drug abuser with soft tissue infection and bacteremia, a circumstance which is in accord with the observation that the M proteins of streptococci causing the most severe forms of localized or invasive human infection possess class I structure. The link between this configuration and rheumatogenicity remains to be defined, however. Our studies of strain 1750, a virulent streptococcus belonging to a serogroup not known to initiate rheumatic fever, suggest that not all M-positive, class I streptococci possess rheumatogenic potential. Thus, if the class I structure is a prerequisite for rheumatogenicity, it is not likely in itself to be sufficient for this purpose.
It should be borne in mind, however, that 1750, as well as the other invasive strains used in our previous and current investigations, initiated disease from a cutaneous or soft tissue site (16) . Further analysis of pharyngeal strains of group G streptococci will be instructive, because only pharyngeal infections with group G streptococci trigger rheumatic fever. Such analysis is complicated, however, by the fact that most throat isolates of group G streptococci are felt to be saprophytes rather than true pathogens. Nevertheless, additional studies along these lines with carefully selected clinical isolates are planned.
